Tyrosine kinase inhibition suppresses angiotensin contraction in hypertensive and normotensive small resistance arteries

Life Sciences

Volumn 58, Issue 19, 1996, Pages 317-324

  Malloy, L G ^a   Sauro, M D ^b  

^a BATES COLLEGE   (United States)

^b SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

Angiotensin II; Protein tyrosine kinases; Spontaneous hypertension; Vascular smooth muscle

Indexed keywords

ACETYLCHOLINE; ANGIOTENSIN; PHENYLEPHRINE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; TYRPHOSTIN 25; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERY CONSTRICTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; GRACILIS MUSCLE; HYPERTENSION; MALE; NONHUMAN; RAT; RESISTANCE BLOOD VESSEL; SMOOTH MUSCLE CONTRACTILITY; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN II; ANIMALS; ARTERIES; ENZYME INHIBITORS; MALE; MUSCLE CONTRACTION; NITRILES; PROTEIN-TYROSINE KINASES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; TYRPHOSTINS; VASCULAR RESISTANCE;

EID: 0009564130     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00147-6     Document Type: Article

References (20)

1. M.D. HOLLENBERG, Trends Pharmacol Sci. 15 108-114 (1994).
2. A. LEVITSKI and C. GILON, Trends Pharmacol. Sci. 12 171-174 (1991).
3. M.D. SAURO, V. HILKER and L.G. MALLOY, Can. J. Pharmacol. 72 162 (1994).
4. M.D. SAURO AND B. THOMAS, Life Sci. 52 371-376 (1993).
5. M.D. SAURO AND B. THOMAS, J. Pharmacol. Exp. Ther. 267 1119-1125 (1993).
6. C. EGLEME, F. CRESSIER and J.M. WOOD, Brit. J. Pharmacol. 100 237-240 (1990).
7. G.H. GIBBONS and V.J. DZAU, Cardiovasc. Drugs Ther. 4 237-242 (1990).
8. S.G. YANG, M. SAIFEDDINE, A. LANIYONU and M. D. HOLLENBERG, J. Pharmacol. Exp. Ther. 264 958-966 (1993).
9. M. SAIFEDDINE, A. LANIYONU, S.G. YANG and M.D. HOLLENBERG, Pharmacol. Comm. 1 177-184 (1992).
10. M.P. OWEN, J.G. WALMSLEY, M.F. MASON, R.D. BEVAN and J.A. BEVAN, Am. J. Physiol. 245 H320-326 (1983).
11. J.A. BEVAN, Circ. Res. 45 161-171 (1979).
12. M.H. LAUGHLIN and J. RIPPERGER, J. Appl. Physiol. 49 627-633 (1987).
13. M.J. MULVANY and W. HALPERN, Nature 260 617-619 (1976).
14. H. NILSSON and M.J. MULVANY, Hypertension 3 691-697 (1981).
15. T. TSUDA, Y, KAWAHARA, K. SHII, M. KOIDE, Y. ISHIDA and M. YOKOYAMA, FEBS Lett. 285 44-48 (1991).
16. A. BOBICK, S. GRINPUKEL, P.J. LITTLE, A. GROOMS and G. JACKMAN, Biochem. Biophys. Res. Commun. 166 580-588 (1990).
17. A. NAFTILAN, R. PRATT and V. DZAU, J. Clin. Invest. 83 1429-1434 (1989).
18. V. BODART, H. ONG and A. DELEAN, Can. J. Pharmacol. 72 555 (1994).
19. J. DESALVO, A. STEUSLOFF, L. SEMENCHUK, S. SATOH, K. KOLQUIST and G. PFITZER, Biochem. Biophys. Res. Commun. 190 968-974 (1993).
20. A. LANIYONU, M. SAIFEDDINE, S.G. YANG and M.D. HOLLENBERG, Can. J. Physiol. Pharmacol. 72 1075-1085 (1994).